Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-25 @ 4:17 AM
NCT ID:
NCT07177820
Eligibility Criteria:
Inclusion Criteria:
* at least 18 years of age
* have histologically confirmed stage I-III breast cancer,
* have completed adjuvant taxane-based chemotherapy (alone or in combination), ,
* have an Eastern Cooperative Oncology Group performance status of 0 or 1, and reported grade 1 or greater CIPN symptoms for more than 2 weeks as defined by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE), version 4.03.
Exclusion Criteria:
* concurrent chemotherapy (there were no limitations on time from the last paclitaxel administration),
* having metastatic or recurrent disease,
* history of preexisting peripheral neuropathy prior to chemotherapy,
* uncontrolled seizure disorder,
* unstable cardiac disease or myocardial infarction within 6 months prior to study entry, being pregnant or nursing, or having used acupuncture for CIPN within 6 months prior to study entry.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT07177820
Study Brief:
Protocol Section:
NCT07177820